MJ Keating

3.8k total citations
54 papers, 3.1k citations indexed

About

MJ Keating is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, MJ Keating has authored 54 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 22 papers in Hematology and 18 papers in Oncology. Recurrent topics in MJ Keating's work include Chronic Lymphocytic Leukemia Research (26 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). MJ Keating is often cited by papers focused on Chronic Lymphocytic Leukemia Research (26 papers), Acute Myeloid Leukemia Research (18 papers) and Acute Lymphoblastic Leukemia research (14 papers). MJ Keating collaborates with scholars based in United States and Australia. MJ Keating's co-authors include KB McCredie, EJ Freireich, Moshe Talpaz, HM Kantarjian, Charles Koller, William Plunkett, Hagop M. Kantarjian, EH Estey, Elihu H. Estey and HM Kantarjian and has published in prestigious journals such as Blood, Leukemia and PubMed.

In The Last Decade

MJ Keating

54 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MJ Keating United States 30 1.7k 1.2k 983 853 722 54 3.1k
EJ Freireich United States 33 1.4k 0.8× 1.8k 1.4× 996 1.0× 791 0.9× 515 0.7× 59 3.4k
L. E. Robertson United States 25 1.8k 1.1× 849 0.7× 1.2k 1.2× 596 0.7× 720 1.0× 41 2.8k
Lawrence D. Piro United States 27 1.7k 1.0× 511 0.4× 1.3k 1.3× 921 1.1× 846 1.2× 59 2.8k
Anna Porwit‐MacDonald Sweden 30 631 0.4× 1.1k 0.9× 938 1.0× 604 0.7× 436 0.6× 50 2.7k
B Desablens France 23 1.2k 0.7× 854 0.7× 1.4k 1.5× 744 0.9× 465 0.6× 89 2.6k
Z Arlin United States 27 820 0.5× 1.7k 1.4× 413 0.4× 766 0.9× 358 0.5× 71 2.8k
R. Kuse Germany 26 703 0.4× 1.4k 1.1× 763 0.8× 734 0.9× 346 0.5× 78 2.4k
Françoise Rigal‐Huguet France 25 837 0.5× 1.3k 1.0× 1.0k 1.0× 869 1.0× 283 0.4× 66 2.7k
Stefan Faderl United States 26 1.7k 1.0× 2.0k 1.6× 1.0k 1.1× 548 0.6× 743 1.0× 115 3.6k
GL Phillips Canada 25 524 0.3× 1.8k 1.4× 532 0.5× 1.1k 1.3× 575 0.8× 56 3.0k

Countries citing papers authored by MJ Keating

Since Specialization
Citations

This map shows the geographic impact of MJ Keating's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MJ Keating with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MJ Keating more than expected).

Fields of papers citing papers by MJ Keating

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MJ Keating. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MJ Keating. The network helps show where MJ Keating may publish in the future.

Co-authorship network of co-authors of MJ Keating

This figure shows the co-authorship network connecting the top 25 collaborators of MJ Keating. A scholar is included among the top collaborators of MJ Keating based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MJ Keating. MJ Keating is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faderl, Stefan, MJ Keating, K-A Do, et al.. (2002). Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL). Leukemia. 16(6). 1045–1052. 103 indexed citations
2.
3.
4.
5.
Trujillo, JM, et al.. (1993). Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia. Blood. 81(10). 2702–2707. 5 indexed citations
6.
Kantarjian, HM, Miloslav Beran, Amy Ellis, et al.. (1993). Phase I study of Topotecan, a new topoisomerase I inhibitor, in patients with refractory or relapsed acute leukemia. Blood. 81(5). 1146–1151. 81 indexed citations
7.
Keating, MJ, S O'Brien, Hagop M. Kantarjian, et al.. (1993). Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood. 81(11). 2878–2884. 148 indexed citations
8.
9.
10.
Kantarjian, HM, Moshe Talpaz, Kapil Dhingra, et al.. (1991). Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia. Blood. 78(9). 2411–2418. 5 indexed citations
11.
Kantarjian, HM, Raymond Alexanian, CA Koller, Razelle Kurzrock, & MJ Keating. (1990). Fludarabine therapy in macroglobulinemic lymphoma. Blood. 75(10). 1928–1931. 2 indexed citations
12.
Gandhi, Varsha, Billie Nowak, MJ Keating, & William Plunkett. (1989). Modulation of arabinosylcytosine metabolism by arabinosyl-2- fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood. 74(6). 2070–2075. 1 indexed citations
13.
Gandhi, Varsha, Billie Nowak, MJ Keating, & William Plunkett. (1989). Modulation of arabinosylcytosine metabolism by arabinosyl-2- fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood. 74(6). 2070–2075. 49 indexed citations
14.
Keating, MJ, et al.. (1985). A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood. 65(5). 1071–1078. 7 indexed citations
15.
Keating, MJ, et al.. (1985). A unique pattern of central nervous system leukemia in acute myelomonocytic leukemia associated with inv(16)(p13q22). Blood. 65(5). 1071–1078. 101 indexed citations
16.
Hittelman, WN, et al.. (1984). Human malignancy-associated nucleolar antigen as a marker for tumor cells in patients with acute leukemia. Blood. 63(3). 676–683. 6 indexed citations
17.
Hittelman, WN, et al.. (1984). Premature chromosome condensation studies in human leukemia: 5. Prediction of early relapse. Blood. 64(5). 1067–1073. 9 indexed citations
18.
Legha, S S, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. Blood. 60(2). 484–490. 4 indexed citations
19.
Legha, S S, MJ Keating, KB McCredie, GP Bodey, & EJ Freireich. (1982). Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adults. Blood. 60(2). 484–490. 85 indexed citations
20.
Keating, MJ, et al.. (1981). Long-term chemotherapy-induced remission in a probable case of hairy cell leukemia.. PubMed. 65(3-4). 313–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by EJ Freireich Breakdown of academic impact, for papers by L. E. Robertson Breakdown of academic impact, for papers by Lawrence D. Piro Breakdown of academic impact, for papers by Anna Porwit‐MacDonald Breakdown of academic impact, for papers by B Desablens Breakdown of academic impact, for papers by Z Arlin Breakdown of academic impact, for papers by R. Kuse Breakdown of academic impact, for papers by Françoise Rigal‐Huguet Breakdown of academic impact, for papers by Stefan Faderl Breakdown of academic impact, for papers by GL Phillips
Rankless by CCL
2026